Scienmag

JUNE 1, 2022

Barcelona, 1 June 2022,– Cancer is increasingly prevalent in society and the efforts of the research community, doctors and administrations to find solutions to this disease are huge. However, it cannot be treated in a uniform way, as there are more than 200 types of cancer.

Genome 75

Genome Genomics Doctor Doctors 75

Medical Xpress

JANUARY 19, 2023

Doctors in a regional hospital in country X note an expanding cluster of individuals with severe respiratory disease. Rapid whole-genome sequencing identifies the disease-causing agent as a novel coronavirus. Imagine it is 2030.

Genomics 64

Genomics Genome Doctor Doctors 64

XTalks

JANUARY 21, 2025

A doctor inserts the catheter through a small incision in a vein in the groin and guides it to the heart. The catheters tip is positioned at various locations within the heart, where the doctor uses a generator to deliver RF energy. The system comprises a delivery catheter and a self-expanding metal stent made of nitinol.

FDA Approval 105

FDA Approval Manufacturing Development RNA 105

Scienmag

JANUARY 27, 2021

Credit: John Wallace, VCU Massey Cancer Center Doctors are increasingly using genetic signatures to diagnose diseases and determine the best course of care, but using DNA sequencing and other techniques to detect genomic rearrangements remains costly or limited in capabilities.

DNA 52

DNA Genome Genomics Doctor 52

pharmaphorum

SEPTEMBER 14, 2022

. “To solve these, the Voice as a Biomarker of Health project is creating a large, high-quality, multi-institutional and diverse voice database that is linked to identity-protected/unidentifiable biomarkers from other data, such as demographics, medical imaging, and genomics,” they add. ” It will be backed by $3.8

Genome 105

Genome Genomics Doctors Doctor 105

pharmaphorum

FEBRUARY 25, 2021

The Scottish Government has supported the transition of genomic testing for inherited rare disease from the research setting into routine care,” she went on. “As On genomics, he added, the country is going “further and faster”, and ensuring synergy between the Rare Disease Framework and the UK Genomic Healthcare Strategy.

Genome 111

Genome Genomics Genetics Medicine 111

pharmaphorum

DECEMBER 21, 2021

In a recent webinar held by pharmaphorum, in partnership with IQVIA, a discussion was held looking at how to make academic and commercial medical research more efficient, while also looking at the opportunity of genomic data to bring benefits to patients and healthcare systems. The potential to leverage genomic data.

Development 98

Development Genome Genomics Drugs 98

pharmaphorum

NOVEMBER 3, 2020

There are no clinical practice guidelines, meaning doctors treat on a case-by-case basis. Another, apparently contradictory, point is that the number of ring 20 diagnoses have actually declined with advances in genome sequencing, which cannot detect the presence of ring chromosomes.

Gene Sequencing 118

Gene Sequencing Gene Genome Genomics 118

pharmaphorum

MARCH 19, 2021

As data and digital technology become vital to every aspect of life sciences, the industry is increasingly looking beyond biologists, chemists, and doctors to drive its drug development – and finding that technology has a chief role to play in the future of medicine. on Big data: astronomical or genomical? ,

Bioinformatics 59

Bioinformatics Drugs Genomics Genome 59

pharmaphorum

JANUARY 24, 2022

That is backed up by a meta analysis of its performance published last year in Nature found that the treatment recommendations delivered by the tool were largely in line with human doctors for several cancer types.

Radiology 111

Radiology Marketing Genome Genomics 111

XTalks

MAY 20, 2022

Doctors and physicians rely on the results provided by a clinical scientist to make an accurate prognosis, diagnosis and assessment for a patient’s treatment plan. Interpret medical tests and confer with doctors and physicians for a suitable prognosis and treatment plan. Their work might involve matching blood samples for transfusions.

Scientist 105

Scientist Life Science Clinical Research Doctors 105

pharmaphorum

NOVEMBER 11, 2020

For pharmaceutical companies, artificial intelligence can help spur drug discovery through finding complex relationships within genomics data. In the US especially, doctors spend much of their time doing administrative tasks that can be automated to save time and reduce errors.

Engineer 139

Engineer Life Science Genome Genomics 139

pharmaphorum

AUGUST 11, 2022

There have been great strides made in genomics to refine tools that determine the safest, most effective course of treatments for patients across a number of disease states. Looking at an individual’s genomic profile also provides an understanding of appropriate medication dosage.

Genome 98

Genome Genomics Drugs Genetics 98

pharmaphorum

APRIL 8, 2022

She collaborated in projects like BIDA-SE (“Possible Uses and Clinical Benefits of Big Data Applications for Rare Diseases”), CORD-MI (“Collaboration for Rare Diseases”) and SATURN (“Smart Doctor Portal for Patients with Unclear Diagnosis”).

Genome 78

Genome Genomics Research Big Data 78

pharmaphorum

JULY 4, 2022

And this is where modern technologies and data-driven medical informatics can really bridge the gaps in rare disease research,” said Dr Joanne Hackett, head of Genomic and Precision Medicine at IQVIA, during a recent pharmaphorum webinar.

Genome 105

Genome Genomics Research Medicine 105

XTalks

FEBRUARY 4, 2021

The power of leveraging clinical data to decipher disease mechanisms and fuel drug discovery has rapidly grown in the era of genomics and personalized medicine. Genuity Science focuses on population genomics as a tool to derive novel biological insights through partnerships with industry-leading pharmaceutical and biotech companies.

Research 98

Research Biobanking Drugs Genome 98

pharmaphorum

MARCH 8, 2022

I was encouraged instead to use my interest in science and study medicine, and I trained to be a hospital doctor at King’s College London. Avideh Nazeri (AN): I always dreamt of having a career that would take me around the world, and when I was younger, I thought I wanted to be a flight attendant.

Life Science 98

Life Science Engineer Scientist Doctors 98

Pharmaceutical Technology

NOVEMBER 4, 2022

And we're building this Data Commons, bringing in imaging data, genomic data, clinical health record data, which in Scotland is really well annotated already,” says McNeil. All data is anonymised to protect patient confidentiality. We're trying to understand why it’s increasing so much across the world, but Scotland in particular.

Medicine 130

Medicine Development Research Gene 130

The Pharma Data

DECEMBER 17, 2020

Dr. Lisa Forbes — his doctor and co-author of a letter describing his case in the Oct. Because he had multiple conditions, his doctors ordered whole genome sequencing to see if they could pinpoint a root cause. WEDNESDAY, Oct. He’s been off insulin since August 2018 — more than two years.

Insulin 52

Insulin Genetics Doctors Doctor 52

pharmaphorum

OCTOBER 6, 2022

He trained in Molecular Biology and earned a doctorate in Genetics from George Washington University, followed by a postdoctoral fellowship at the National Institute of Aging in the Microarray Core. He served as Director of the Lowe Family Genomics Core at the Johns Hopkins University from 2005-15.

In-Vivo 98

In-Vivo Research Genetics Drugs 98

The Pharma Data

SEPTEMBER 1, 2021

“Doctors often treat patients who have rheumatoid arthritis with injections or infusions of anti-inflammatory biologic drugs, but those drugs can cause significant side effects when delivered long enough and at high enough doses to have beneficial effects,” said senior investigator Farshid Guilak, PhD, the Mildred B.

Drugs 52

Drugs Engineer Drug Delivery Gene 52

pharmaphorum

JUNE 15, 2021

Every patient, every doctor or nurse, every hospital worker is a human being influenced by their experiences outside of healthcare. centric care model to a more virtual distributed care model that heavily leverages the latest technologies around artificial intelligence, deep learning, data analytics, genomics, home?based

Big Data 52

Big Data Nurses Genome Genomics 52

Pharmaceutical Technology

FEBRUARY 28, 2023

This often puts patients in difficult situations where they are passed between doctors until a correct diagnosis is reached. The next generation of orphan drug launches Looking at some of the more recent orphan drug approvals, it is clear that advancements in genomic medicine are now shaping the next generation.

Medicine 130

Medicine Marketing Production Drugs 130

pharmaphorum

FEBRUARY 26, 2021

Every time a patient with a rare condition walks into a hospital, doctors face the probable challenge of starting from scratch. For instance, the UK government’s 100K Genomes Project has achieved its goal of sequencing the genomes of 100,000 people in 2019.

Drugs 78

Drugs Genome Project Genome Genomics 78

pharmaphorum

MARCH 19, 2021

Approximately 85% of rare diseases are genetic, offering significant opportunities to develop better treatments as our understanding of the human genome improves 1. However, often rare disease patients are ignored by doctors, researchers, and the general public.

Branding 52

Branding Genome Genomics Genetics 52

XTalks

JULY 24, 2024

Large datasets from clinical trials, patient records and genomic studies can be analyzed to identify patterns and correlations previously unattainable. This tool helps doctors make more informed decisions about biopsies and treatment options, reducing unnecessary procedures. Nanostics Inc.

Big Data 52

Big Data Clinical Trials Clinical Trials Life Science 52

Pharma Marketing Network

OCTOBER 24, 2024

Personalized medicine, often driven by genomic data, is revolutionizing how treatments are marketed. Imagine being able to predict how well a drug will perform in a specific market or which doctors are more likely to prescribe a new therapy. That’s the power of AI in pharma.

Marketing 52

Marketing Branding Pharma Companies Compliance 52

The Pharma Data

SEPTEMBER 6, 2021

Genomic data from the phase II CUPISCO study in Cancer of Unknown Primary (CUP), an uncommon type of cancer with high unmet need, could support diagnostics and more personalised treatment plans. In CUP, doctors cannot identify the location of the original (primary) tumour and can only find metastases. Comprehensive genomic profiling.

Genome 52

Genome Genomics HR Hormones 52

Delveinsight

AUGUST 11, 2021

Virtual and Augmented Reality Programs are aiding doctors by making patients see a complete technique of how a surgery is performed. Genome Sequencing. Certain procedures like targeting a chemical combination that might be optimum to create a drug, reducing human time is crucial aid to drug discovery.

Medicine 90

Medicine Drug Delivery Development Drug Delivery Systems 90

The Pharma Data

DECEMBER 29, 2020

” Some patients needed weeks in the hospital before doctors could find a medication that worked. The World Health Organization (WHO) says steps to expand the sequencing of the genome of new variants of the coronavirus are needed as the pandemic enters its second year, the Associated Press reported. ” © 2020 HealthDay.

Genome 52

Genome Genomics Immune Response Doctors 52

Delveinsight

FEBRUARY 17, 2021

The wearables collect and analyze users’ real-time medical data, which is more comfortable for physicians and doctors to examine. The collected data and the genomic studies can play a crucial role in monitoring the symptoms and predicting potential diseases. . Cybersecurity in Healthcare.

Doctors 52

Doctors Doctor Big Data Development 52

Bioengineer

JULY 22, 2021

Bracken and his team working in the laboratory, and doctors in the clinical setting, this will hopefully lead to the improved outcomes that we all so dearly wish to see.” We are now entering an exciting era of expansion of our knowledge of this disease at a molecular level, which in turn will lead us towards more targeted treatments.

Genetics 52

Genetics Drugs Clinical Trials Clinical Trials 52

Roots Analysis

SEPTEMBER 4, 2024

After the test, results are sent to the doctor, who can use the test information to make informed decision about the patient’s treatment. These specimens are then sent to a dedicated laboratory or testing facility, where required tests are performed, and samples are analyzed using several diagnostic techniques and instruments.

Marketing 40

Marketing In-Vitro Compliance Development 40

The Pharma Data

DECEMBER 15, 2020

Such cooperation will rapidly expand the coverage of the drug product after its launch, providing professional pharmaceutical services to doctors and patients, and benefit more patients.” ” About CHIPSCREEN BIOSCIENCES. Shenzhen Chipscreen Biosciences Co., Chipscreen Biosciences, Stock Symbol: 688321.SH)

Insulin 40

Insulin Drugs Production Clinical Trials 40

XTalks

SEPTEMBER 16, 2024

Dr. Adam: As with most trials, meeting patients in their own communities where they prefer to be treated by doctors they know and trust, is a challenge for Lung-MAP. How does Lung-MAP manage the extensive data from genomic profiling and multiple sub-studies? What role does technology play in supporting the trial’s infrastructure?

Clinical Trials 52

Clinical Trials Clinical Trials Trials Clinical Research 52

XTalks

OCTOBER 19, 2023

This specialization can often be achieved during graduate research, post-doctoral work or industry-specific training programs. Additionally, advances in technologies in fields like genomics, proteomics and cell biology necessitate specialized assays. Interning provides industry-relevant experience and can also help with networking.

Scientist 59

Scientist Development Research Compliance 59

The Pharma Data

JANUARY 4, 2021

Longwood has a robust research department with 7 post doctorates conducting research in molecular biology, microbiology, genomics, cancer biology, and immunology and publishing over 75 publications in different scientific journals in the past 5 years. Barber also serves on Kiromic’s Scientific Advisory Board. About Longwood University.

In-Vivo 40

In-Vivo Development Immune Response Big Data 40